Regulatory science for biomaterials: are we doing right things right? Abstract
Article Sidebar
Main Article Content
Abstract
The aim of this work is to highlight gaps and drawbacks in modern development of biomaterials which are intended themselves alone or in combination to be deployed in medical devices, especially for Class III under the EU MDR 2017/745. More tight requirements for biomaterials safety and efficacy demand proper testing and assessment which might be not always aligned with the R&D process.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors grant to the Publisher the following rights to the manuscript, including any supplemental material, and any parts, extracts or elements thereof:
- the right to reproduce and distribute the Manuscript in printed form, including print-on-demand;
- the right to produce prepublications, reprints, and special editions of the Manuscript;
- the right to translate the Manuscript into other languages;
- the right to reproduce the Manuscript using photomechanical or similar means including, but not limited to photocopy, and the right to distribute these reproductions;
- the right to reproduce and distribute the Manuscript electronically or optically on any and all data carriers or storage media – especially in machine readable/digitalized form on data carriers such as hard drive, CD-Rom, DVD, Blu-ray Disc (BD), Mini-Disk, data tape – and the right to reproduce and distribute the Article via these data carriers;
- the right to store the Manuscript in databases, including online databases, and the right of transmission of the Manuscript in all technical systems and modes;
- the right to make the Manuscript available to the public or to closed user groups on individual demand, for use on monitors or other readers (including e-books), and in printable form for the user, either via the internet, other online services, or via internal or external networks.
How to Cite
Funding data
-
Horizon 2020 Framework Programme
Grant numbers 760921;952033
References
Gasik M. Understanding biomaterial-tissue interface quality: combined in vitro evaluation. Sci. Techn. Adv. Mater. (2017), 18:550-562. https://doi.org/10.1080%2F14686996.2017.1348872
Zuhlke A. Dynamic mechanical characterization of biomaterials for medical devices. Aalto University Doctoral Theses (2023), 148 p. https://urn.fi/URN:ISBN:978-952-64-1255-9
Gasik M. Biomechanical characterization of engineered tissues and implants for tissue/organ replacement applications. In: Biomaterials for Organ and Tissue Regeneration, Eds. E.N. Vrana, H. Knopf-Marques, J. Barthes, Woodhead Publ. (2020), 599-627. https://shop.elsevier.com/books/biomaterials-for-organ-and-tissue-regeneration/vrana/978-0-08-102906-0